Equity Analysis

Key Financial Ratios
    Zydus Lifesciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532321
    INE010B01027
    145.1076344
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ZYDUSLIFE
    35.49
    95380.92
    EPS(TTM)
    Face Value()
    Div & Yield %:
    26.71
    1
    0.64
     
   ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.280.250.320.370.40
Long Term Debt-Equity Ratio0.150.030.090.180.21
Current Ratio1.861.381.261.361.30
Fixed Assets1.111.071.151.001.13
Inventory4.714.234.904.434.32
Debtors3.023.753.572.783.59
Interest Cover Ratio8.3012.0227.517.9120.95
PBIDTM (%)32.0626.8030.8735.9237.02
PBITM (%)26.4620.6925.0729.1631.09
PBDTM (%)28.8725.0729.9632.2335.54
CPM (%)23.1120.0926.7929.0230.54
APATM (%)17.5113.9820.9922.2624.61
ROCE (%)13.319.8412.2213.5316.34
RONW (%)11.388.4313.6114.2518.21